KESIMPTA Co-pay Card (Alongside Kesimpta)
Novartis Pharmaceuticals · Kesimpta
Patient pays: as little as $0 (97% of commercially insured patients pay $0)
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Kesimpta assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Kesimpta help that still works on Medicare or Medicaid - the programs copay cards leave out.
Kesimpta (ofatumumab) is an anti-cd20 monoclonal antibody (sc self-injection) made by Novartis. It is commonly prescribed for: Relapsing forms of multiple sclerosis. Without financial assistance, Kesimpta typically costs around $7,400 per month.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Novartis Pharmaceuticals · Kesimpta
Patient pays: as little as $0 (97% of commercially insured patients pay $0)
commercial insurance
Novartis Pharmaceuticals · Kesimpta
Patient pays: free Kesimpta for up to 12 months while seeking coverage
commercial pending coverage
Novartis Patient Assistance Foundation · Kesimpta
uninsured · Medicare Part D · underinsured
Common questions
Related drugs